Spineology has received US Food and Drug Administration (FDA ) clearance for its new Rampart line of Interbody fusion implants.
The interbody fusion system is incorporated with implantation equipment designed to enhance a surgeon’s ability to position the implant within the disc space.
The Rampart line will feature a variety of implant configurations, lengths and heights providing the surgeon with several options to fit patient needs.
The company is committed to increasing procedural efficiency, reducing surgical morbidity and accelerating patient recovery.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData